Skip to main content
TipRanks
Go Ultimate75% OFF

Nouveau Life Pharmaceuticals (NOUV) Stock Statistics & Valuation Metrics

29 Followers

Total Valuation

Nouveau Life Pharmaceuticals has a market cap or net worth of $6,661.00. The enterprise value is $0.00.

Market Cap
$6,661.00
Enterprise Value
$0.00

Share Statistics

Nouveau Life Pharmaceuticals has 6,660,964,000 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
6,660,964,000
Owned by Insiders
―
Owned by Institutions
<0.01%

Financial Efficiency

Nouveau Life Pharmaceuticals’s return on equity (ROE) is 0.00 and return on invested capital (ROIC) is 0.00%.

Return on Equity (ROE)
0.00
Return on Assets (ROA)
0.00
Return on Invested Capital (ROIC)
0.00%
Return on Capital Employed (ROCE)
0.00
Revenue Per Employee
―
Profits Per Employee
―
Employee Count
0
Asset Turnover
0.00
Inventory Turnover
0.00

Income Statement

In the last 12 months, Nouveau Life Pharmaceuticals had revenue of 0 and earned 0 in profits. Earnings per share was 0.00.

Revenue
0
Gross Profit
0
Operating Income
0
Pretax Income
0
Net Income
0
EBITDA
0
Earnings Per Share (EPS)
0.00

Stock Price Statistics

Beta
154.34
52-Week Price Change
―
50-Day Moving Average
―
200-Day Moving Average
―
Relative Strength Index (RSI)
―
Average Volume (3m)
―

Financial Position

Nouveau Life Pharmaceuticals as a current ratio of 0.00, with Debt / Equity ratio of 0.00%

Current Ratio
0.00
Quick Ratio
0.00
Debt to Market Cap
0.00
Net Debt to EBITDA
0.00
Interest Coverage Ratio
0.00

Taxes

In the past 12 months, Nouveau Life Pharmaceuticals has paid 0 in taxes.

Income Tax
0
Effective Tax Rate
0.00

Analyst Forecast

The average price target for Nouveau Life Pharmaceuticals is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target
―
Price Target Upside
―
Analyst Consensus
―
Analyst Count
0
Revenue Growth Forecast
―
EPS Growth Forecast
―